Welcome to Monday’s Overnight Health Care, where we’re following the latest moves on policy and news affecting your health. Subscribe here: thehill.com/newsletter-signup.
It's beginning to look a lot like Christmas at the White House – even before Thanksgiving – as Jill BidenJill BidenWhite House holiday decorations available for 360 tour via Google Street View The Hill's Morning Report - Presented by Facebook - Congress avoids shutdown The Hill's Morning Report - Presented by Facebook - Biden talks up bright side beneath omicron's cloud MORE welcomed the White House’s tree for the first time as first lady.
According to the White House, more than 90 percent of federal workers are vaccinated against COVID-19 ahead of today's deadline.
For The Hill, we’re Peter Sullivan (email@example.com), Nathaniel Weixel (firstname.lastname@example.org) and Justine Coleman (email@example.com). Write to us with tips and feedback, and follow us on Twitter: @PeterSullivan4, @NateWeixel and @JustineColeman8.
Let’s get started.
Most federal workers vaccinated by deadline
More than 90 percent of the federal workforce has received at least one shot of a COVID-19 vaccine, the White House said Monday, the deadline for President BidenJoe BidenMarcus Garvey's descendants call for Biden to pardon civil rights leader posthumously GOP grapples with chaotic Senate primary in Pennsylvania Trump social media startup receives commitment of billion from unidentified 'diverse group' of investors MORE’s federal employee mandate.
Another roughly 5 percent are in compliance by having a valid exception or an extension request, a senior administration official said, bringing the total to 95 percent in compliance.
For the small percentage of employees who are not in compliance, which still translates to thousands of people out of more than 3.5 million federal workers, “agencies are beginning an education and counseling process, followed by additional enforcement steps over time if needed,” the official said.
Broader push: The Biden administration hopes the high uptake among federal workers is an example for private sector employers, as part of a larger vaccine mandate push. The administration’s vaccination-or-testing requirement for businesses with 100 or more workers is scheduled to take effect Jan. 4, though it is currently paused by a federal appeals court.
“As the progress across the Federal government has shown, these requirements work — and we hope that our implementation can serve as an example for other businesses of every size to move forward with similar measures that will protect their workforce, protect their customers, and protect our communities,” the senior administration official said.
Fauci: Dont ‘prematurely’ end mask mandates
Top infectious diseases expert Anthony FauciAnthony FauciStudy: Omicron could be more transmissible due to sharing genetic material with common cold Sunday shows preview: Multiple states detect cases of the omicron variant Three omicron cases of COVID-19 identified in Maryland: Gov. Hogan MORE warned on Monday about “prematurely” dropping mask mandates as Washington, D.C., lifts its requirement for indoor masking despite opposition from the city’s council members.
President Biden’s chief medical adviser told NPR’s “Morning Edition” that the city's move “adds an extra degree of risk” as the country sees rising cases and hospitalization while it heads into the holiday season.
“When you have a dynamic like that ... you really gotta be careful,” he said. “Masks are not going to be forever for sure. The more people that get vaccinated, the more people that get boosted, the lower the level of infection in the community will be, and then you start thinking about pulling back on masks.”
“But you don’t want to do it prematurely,” he added. “As much as you’d like to do it, you’ve got to be careful.”
Fauci pointed to the national increase in cases, citing that they are up 29 percent from two weeks earlier. Hospitalizations have ticked up 6 percent, while deaths still are decreasing, although he cautioned fatalities are “usually a lagging indicator.”
What’s next: When asked about when mask mandates can end, Fauci said it’s “tough to predict” but he hopes it’s “as we get through the winter and into the spring.”
“But you can’t guarantee it,” he added. “This virus has fooled us before. It’s a very wily virus — this delta variant.
GROUPS PRESS BIDEN ON INTELLECTUAL PROPERTY WAIVER FOR COVID-19 VACCINE
More than a dozen medical and human rights groups have teamed up to call on President Biden to take action supporting an intellectual property waiver for COVID-19 vaccines, seeking to keep pressure on the administration in an effort to improve global access to the shots.
The 15 organizations, including Doctors Without Borders, Human Rights Watch and Public Citizen, sent a letter to the White House on Friday requesting Biden’s “personal engagement” on the matter. The groups are pushing for a temporary waiver at the World Trade Organization (WTO) to boost production and supplies for COVID-19 vaccines, treatments and tests.
The groups said they’re “very disappointed” with the Biden administration for its lack of action, beyond the president’s May endorsement, “as millions die or become seriously ill waiting for effective vaccines and treatments.”
The administration has previously declared its support for an intellectual property waiver for the COVID-19 vaccines in May. The White House also called on all WTO members to back an intellectual property waiver for the vaccines last month.
But the organizations said in the letter that there’s been “no progress on enacting it.”
The groups called for movement on this waiver at the upcoming WTO Ministerial Conference slated for the end of this month.
House seeks interview with former FDA leader
The House subcommittee investigating the U.S. response to the coronavirus wants to question Stephen HahnStephen HahnThe Hill's Morning Report - Ins and outs: Powell renominated at Fed, Parnell drops Senate bid Overnight Health Care — White House touts vaccine rate for feds House COVID-19 panel seeks interview with former Trump FDA leader Hahn MORE, former President TrumpDonald TrumpGOP grapples with chaotic Senate primary in Pennsylvania Trump social media startup receives commitment of billion from unidentified 'diverse group' of investors Iran thinks it has the upper hand in Vienna — here's why it doesn't MORE's Food and Drug Administration commissioner, about attempts to improperly interfere with the agency's review of COVID-19 therapeutics and vaccines, and to boost drugs with minimal benefit.
The committee on Monday sent a letter to Hahn asking him to sit for an interview on Dec. 16, and to provide documents and communications by Dec. 6.
The FDA faced an onslaught from political appointees across the government to fast track approvals of therapeutics and vaccines that would show the Trump administration had the pandemic under control, including hydroxychloroquine and convalescent plasma.
"Given the sustained campaigns to promote the use of dubious coronavirus treatments, the Select Subcommittee seeks to understand the full extent and impact of Trump Administration officials’ efforts to influence these FDA decisions," panel chairman Rep. James Clyburn (D-S.C.) wrote.
Seeking answers: The committee wants information about Trump officials' efforts to promote the use of chloroquine and hydroxychloroquine, antimalarial drugs that Trump touted as a miracle cure, despite no evidence.
The agency granted emergency use authorization for hydroxychloroquine in late March of 2020. The panel cited messages between Hahn and other agency officials expressing concerns that hydroxychloroquine was ineffective and potentially dangerous; the FDA did not formally revoke the authorization until June.
The panel also wants to learn more about the authorization of convalescent plasma. The FDA rushed to issue an emergency use authorization for plasma on August 23, 2020, after Trump pressured the agency to move faster in pushing out coronavirus treatments and vaccines, despite scientists saying more research was needed.
AMA WARNS OF SEVERE, IRREPARABLE HARM IF VACCINE MANDATE IS HALTED
The American Medical Association (AMA) warned that stopping the Biden administration's coronavirus vaccine or testing requirements for private businesses would "severely and irreparably harm the public interest."
In a filing with the U.S. Court of Appeals for the 5th Circuit, the AMA said COVID-19 presents a "grave danger to the public" that "wreaked havoc in communities across the country." The association said it submitted the friend of the court brief because it has "an interest in providing evidence-based guidance on public health issues."
The 5th Circuit has since put a nationwide pause on the order, but now all the lawsuits have been condensed in the 6th Circuit, which has yet to rule on any motions.
Specifically, the doctor's association noted that COVID-19 transmissions in the workplace were a large part of the virus's spread in a variety of industries.
"The more workers who get vaccinated, the closer we are to slowing the spread of the virus and creating a safer environment," the AMA said.
The filing also called vaccine requirements a "critical" part of bringing the pandemic to an end, referencing previous vaccine mandates for illnesses like measles and smallpox.
WHAT WE'RE READING
- Stubborn Covid surges signal bleak winter (Politico)
- Medical debt is crushing Black Americans, and hospitals aren’t helping (Bloomberg News)
- Concerns grow over safety of Aduhelm after death of patient who got the drug (New York Times)
- Why you can’t find cheap at-home Covid tests (Kaiser Health News)
STATE BY STATE
- Doctor who swabbed Cuomo describes a health department in shambles (The New York Times)
- Right-wing groups take personal freedoms fight to Michigan schools (Detroit Free Press)
- Most of Idaho exits crisis standards of care (Boise State Public Radio)
That’s it for today, thanks for reading. Check out The Hill’s health care page for the latest news and coverage. See you Tuesday.